Pulse Biosciences, Inc.
Pulse Biosciences, Inc.（PLSE）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · PLSE · 截至 2025年9月30日
股东结构概览
85
机构持有人数
▼ 2 vs Q2
$104.04M
机构持仓总市值
▲ $13.73M vs Q2
69.21M
总流通股
freeFloat 18.45%
5.88M
13F 申报持股数
▼ 106,671 vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
PLSE 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
BLACKROCK, INC. surgical & medical instruments & apparatus | 1.31M | 1.94% | 1.94% | $23.15B | Nov 12, 2025 | ▼ 36.4K |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 1.11M | 1.66% | 1.66% | $19.71B | Nov 7, 2025 | ▼ 110.1K |
BANK OF AMERICA CORP /DE/ surgical & medical instruments & apparatus | 805.0K | 1.20% | 1.20% | $14.25B | Feb 3, 2026 | ▲ 21.4K |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 469.5K | 69.79% | 69.79% | $8.31B | Nov 12, 2025 | ▼ 30.0K |
STATE STREET CORP surgical & medical instruments & apparatus | 421.9K | 62.71% | 62.71% | $7.47B | Nov 14, 2025 | ▲ 2.6K |
GRIFFIN ASSET MANAGEMENT, INC. surgical & medical instruments & apparatus | 227.3K | 33.79% | 33.79% | $4.02B | Oct 16, 2025 | ▼ 2.3K |
NORTHERN TRUST CORP surgical & medical instruments & apparatus | 192.6K | 28.63% | 28.63% | $3.41B | Nov 14, 2025 | ▼ 4.8K |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC surgical & medical instruments & apparatus | 152.7K | 22.69% | 22.69% | $2.70B | Nov 10, 2025 | ▼ 19.7K |
PORTOLAN CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 102.2K | 15.19% | 15.19% | $1.81B | Nov 13, 2025 | NEW |
UBS GROUP AG surgical & medical instruments & apparatus | 76.9K | 11.42% | 11.42% | $1.36B | Nov 13, 2025 | ▲ 26.7K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
21
增持
+170.4K 股4
新建仓
首次建仓18
减持
−321.8K 股0
清仓
完全退出净股数变化（前50家）
151.4K
+170.4K / −321.8K
净新增持仓人
+7
新建 4 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
PLSE 内幕交易记录
数据来源：SEC Form 4
近期内部人员净买入。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
3
买入笔数
0
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
DUGGAN ROBERT W
| May 11, 2026 | Purchase | 660,233 | $19.69 | $13.00M | 48.37M | Form 4 ↗ |
LAVIOLETTE PAUL A Chief Executive Officer | May 11, 2026 | Purchase | 15,000 | $19.69 | $295.4K | 15.8K | Form 4 ↗ |
LAVIOLETTE PAUL A Chief Executive Officer | May 11, 2026 | Purchase | 15,000 | $19.69 | $295.4K | 15.0K | Form 4 ↗ |
DUGGAN ROBERT W
| May 11, 2026 | Purchase | 660,233 | $19.69 | $13.00M | 48.21M | Form 4 ↗ |
UECKER DARRIN Chief Technology Officer | Mar 23, 2026 | Award | 100,000 | — | — | 100.0K | Form 4 ↗ |
Danahy Kevin Patrick Chief Commercial Officer | Feb 18, 2026 | Sale | 5,000 | $23.64 | $118.2K | 43.3K | Form 4 ↗ |
Danahy Kevin Patrick Chief Commercial Officer | Feb 12, 2026 | Sale | 20,000 | $23.37 | $467.4K | 43.3K | Form 4 ↗ |
Danahy Kevin Patrick Chief Commercial Officer | Feb 13, 2026 | Sale | 20,000 | $23.53 | $470.6K | 43.3K | Form 4 ↗ |
Danahy Kevin Patrick Chief Commercial Officer | Feb 17, 2026 | Sale | 20,000 | $23.63 | $472.6K | 43.3K | Form 4 ↗ |
Danahy Kevin Patrick Chief Commercial Officer | Feb 10, 2026 | Sale | 20,000 | $23.52 | $470.4K | 43.3K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Pulse Biosciences, Inc.（PLSE）主要由机构投资者持有，机构持股比例约为 8.5%。公司内部人员持股约 81.55%，散户及公众持股约占剩余的 9.96%。
Pulse Biosciences, Inc. 最大机构股东为 BLACKROCK, INC.，截至 September 30, 2025 持有约 1.31 million 股，占总流通股的 1.94%。
目前共有 85 家机构持有 PLSE 股票，合计持仓市值约 $104,037,361，数据来源为最新 SEC 13F 申报。
常见问题
PLSE ownershipPulse Biosciences, Inc.（PLSE）主要由机构投资者持有，机构持股约 8.5%。最大股东为 BLACKROCK, INC.，持股比例 1.94%。内部人员持股约 81.55%。数据来源 SEC Form 13F，截至 September 30, 2025。